OncoTherapy Science Inc
30O
Company Profile
Business description
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.
Contact
11th Floor, Kanagawa Science Park R&D
3-2-1 Sakado
Kanagawa
Kawasaki213-0012
JPNT: +81 448208251
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 March 2026
Employees
53
Stocks News & Analysis
stocks
What Q4 US earnings did and didn’t tell us about AI and the outlook for tech shares
Tech saw solid earnings, but there are more questions around which companies will benefit from AI, and which will be hurt.
stocks
Top stocks of the year: Which opportunities remain in 2026?
A deep dive into the most traded stocks by Aussies in 2025 - and what this signals for the year ahead.
stocks
What did Morningstar subscribers buy and sell during February?
How the most traded shares stack up against our analysts views.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,067.30 | 18.50 | 0.20% |
| CAC 40 | 8,045.80 | 121.93 | -1.49% |
| DAX 40 | 23,815.75 | 389.61 | -1.61% |
| Dow JONES (US) | 47,954.74 | 784.67 | -1.61% |
| FTSE 100 | 10,413.94 | 153.71 | -1.45% |
| HKSE | 25,761.85 | 440.51 | 1.74% |
| NASDAQ | 22,748.99 | 58.50 | -0.26% |
| Nikkei 225 | 55,294.08 | 16.02 | 0.03% |
| NZX 50 Index | 13,507.23 | 110.66 | -0.81% |
| S&P 500 | 6,830.71 | 38.79 | -0.56% |
| S&P/ASX 200 | 8,832.30 | 7.10 | 0.08% |
| SSE Composite Index | 4,118.68 | 10.12 | 0.25% |